📰 Payload Modification Technology News
Payload Modification Technology News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Payload Modification Technology. Real-time updates on events, politics, business and more.
January 3, 2024
/PRNewswire/ -- WuXi XDC, a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on ADC and the other types of...
January 3, 2024
WuXi XDC and IntoCell signed MOU for a partnership in drug-linker technology and CRDMO services covering right from discovery to commercialisation.
January 5, 2023
/PRNewswire/ -- IntoCell today announced the signing of a Material Transfer Agreement (MTA) with option to license with ADC Therapeutics SA (NYSE: ADCT). Under...
January 5, 2023
London-based deal experts are the advisors for this collaboration and the ongoing partnering efforts for IntoCell's platform technologies and its lead programme, B7-H3 ADC. LONDON, Jan.
October 15, 2021
/PRNewswire/ -- PharmaVentures is pleased to announce that it acted as the lead advisor to IntoCell on its new research collaboration with Ab Studio. This...
October 14, 2021
/PRNewswire/ -- IntoCell, a South Korean biotech developing novel antibody drug conjugate (ADC) platform technologies, today announced the signing of a...